Sanatorio del Sur S.A.

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Epilepsy3 trials
• Multiple sclerosis2 trials
• Alzheimer disease1 trial

Phase

• Phase 34 trials
• Phase 22 trials

Status

• Active, not recruiting2 trials
• Completed2 trials
• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• Hoffmann-La Roche3 trials
• Xenon Pharmaceuticals Inc.3 trials

Running trials

• Active, not recruiting

  A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)

  NCT07074886· Phase 2· Hoffmann-La Roche· Source

• Recruiting

  A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)

  NCT07161258· Phase 2· Hoffmann-La Roche· Source

• Enrolling by invitation

  An Open-label Study of XEN1101 in Epilepsy

  NCT05718817· Phase 3· Xenon Pharmaceuticals Inc.· Source

• Recruiting

  A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

  NCT05667142· Phase 3· Xenon Pharmaceuticals Inc.· Source

  Contact: Xenon Medical Affairs

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Epilepsy1 recruiting
• Multiple sclerosis1 recruiting

Closed trials

• Recruiting

  Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  NCT07177352· Phase 3· Hoffmann-La Roche· Source

• Completed

  A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

  NCT05614063· Phase 3· Xenon Pharmaceuticals Inc.· Source